Back to search

Michigan State University

Disruption of cellular Calcium homeostasis and mitochondrial function following chronic methylmercury treatment

Abstract

dc:description

Methylmercury (MeHg) is a potent environmental neurotoxicant that impairs several neurological functions upon short and long-term exposure. MeHg causes cell-type specific damage in the cerebellum and this effect seems to be due to a disruption of intracellular calcium ([Ca2+]i) homeostasis and voltage-gated Ca2+ channel (VGCC) function. The striatum may be a sensitive target due to its high expression of Cav1.3, an L-type VGCC. Exposure to low levels of MeHg throughout ones lifetime is of contemporary concern. In viro and in vivo studies were designed to mimic a lifetime exposure to low-levels of MeHg. Following prolonged exposure to low-nanomolar MeHg in vitro we found that MeHg causes a time- and subtype-dependent block of VGCCs, as well as increased resting [Ca2+]i. Chronic MeHg exposure in vivo suggests that MeHg interacts with AMPA receptors altering the post-synaptic response to glutamate at striatal medium spiny neurons. Chronic MeHg treatment also altered striatal synaptosomal mitochondrial function. This work contributes to our understanding of the consequences of long-term exposure to MeHg on neuronal function.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ciotti, Sara Michelle
Contributors dc:contributor
  • Atchison, William D.
  • Barman, Susan
  • Heidemann, Steven
  • Goudreau, John

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language
English

Identifiers

dc:identifier.*
Identifier
etd:2789
isbn:9781303642135
isbn:1303642131
oclc:931750198
umi:3606891
local:Ciotti_grad.msu_0128D_12661

Chain of custody

source
Harvested from
Michigan State University
Base URL
d.lib.msu.edu/oai
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ciotti, Sara Michelle. Disruption of cellular Calcium homeostasis and mitochondrial function following chronic methylmercury treatment. 2013.